Samsung Bioepis Gets FDA Approval for Biosimilar of J&J’s Stelara

Samsung Bioepis Gets FDA Approval for Biosimilar of J&J’s Stelara

Submitted by admin on July 1, 2024 - 9:58pm
Source: 
BioSpace
News Tags: 
Samsung Bioepis
FDA
Pyzchiva
biosimilars
JNJ
Stelara
Headline: 
Samsung Bioepis Gets FDA Approval for Biosimilar of J&J’s Stelara
snippet: 

Samsung Bioepis announced Monday that the FDA has approved Pyzchiva (ustekinumab—ttwe), a biosimilar of Johnson & Johnson’s blockbuster immunotherapy Stelara.

Do Not Allow Advertisers to Use My Personal information